{
    "code": "02021444",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021444",
    "time": "2015-08-23 11:56:04",
    "許可證字號": "衛署藥輸字第021444號",
    "註銷狀態": "已註銷",
    "註銷日期": "98\/12\/31",
    "註銷理由": "屆期未申請展延",
    "有效日期": "90\/11\/20",
    "發證日期": "85\/11\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202144407",
    "中文品名": "翩大密丁注射劑",
    "英文品名": "PENTAMIDINE ISETHIONATE FOR INJECTION \"DBL\"",
    "適應症": "治療因ＰＮＥＵＭＯＣＹＳＴＩＳ　ＣＡＲＩＮＩＩ　感染而引發ＰＮＥＵＭＯＣＹＳＴＩＳ　ＣＡＲＩＮＩＩ　ＰＮＥＵＭＯＮＩＡ　（ＰＣＰ）、尤其是免疫不全者併發之ＰＣＰ病人",
    "劑型": "243凍晶注射劑",
    "包裝": "小瓶",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "0906901100  恆振企業有限公司",
    "申請商地址": "台北巿永吉路３０２號４Ｆ之２",
    "主製造廠": {
        "製造廠名稱": "F020007000  DAVID BULL LABORATORIES",
        "製造廠廠址": "7-23 LEXIA PLACE, MULGRAVE VICTORIA 3170,AUSTRALIA",
        "製造廠公司地址": "",
        "製造廠國別": "AUSTRALIA",
        "製程": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses,put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": []
}